This study showed a trend for decreased ΔAGT values in the patients who used RAS blockers than those who did not use RAS blockers. ΔAGT values were inversely significantly correlated with change in eGFR among patients who did not use RAS blockers during the follow-up period, but not in those who used RAS blockers.
← all excerpts
Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
1
—
—